James Assmann is an associate at Lowenstein Sandler. James was previously an associate at Reed Smith LLP from September 2019 to November 2021. Prior to that, they were a senior legal specialist at Merck from August 2016 to August 2019. From June 2008 to July 2016, they worked in preclinical research and development at Novartis Institutes for BioMedical Research (NIBR). James also worked as a laboratory intern at NIBR from June 2005 to December 2007.
James Assmann received their Juris Doctor from Rutgers Law School, where they also completed a Corporate & Business Law Certificate. James then went on to earn their Master of Science in Health Care Management from Saint Elizabeth University. Finally, they completed their Bachelor of Business Administration at Loyola University Maryland, where they majored in Business Management with an International Business Concentration.